Skip to main content

Table 3 Characteristics of oral AMT supply and demand

From: Insights into the availability and distribution of oral artemisinin monotherapy in Myanmar: evidence from a nationally representative outlet survey

 

National

%

(95% CI)

Proportion of oral AMT products that were reportedly obtained from

N = 1335

 Pharmacy

53.5

(47.3, 59.7)

 Fixed-location medicine wholesale outlet

40.0

(33.5, 46.6)

 Other (mobile distributor, village buyer, rural health centres, and ‘floating shops’)

8.1

(5.3, 10.9)

Proportion of oral AMT products that were reportedly obtained from a supplier within the past 3 months

53.1

(47.1, 59.0)

 

Median

[IQR] (N)

Among oral AMT products, median

 Number of oral AMT packages in stock on the day of the survey

1.0

[0.4–2.4](1302)

 

%

(95% CI)

Proportion of oral AMT products* that

 Were reportedly requested by name by consumers

68.2

(63.0, 73.4)

  1. *Oral AMT products in stock on the day of the survey or reportedly in stock in the past three months